SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011227
Filing Date
2018-08-09
Accepted
2018-08-09 08:16:46
Documents
56
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 613587
2 ex3-1.htm EX-3.1 33456
3 ex31-1.htm EX-31.1 8565
4 ex31-2.htm EX-31.2 8497
5 ex32-1.htm EX-32.1 7015
  Complete submission text file 0001493152-18-011227.txt   2823969

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cocp-20180630.xml EX-101.INS 385701
7 XBRL SCHEMA FILE cocp-20180630.xsd EX-101.SCH 37554
8 XBRL CALCULATION FILE cocp-20180630_cal.xml EX-101.CAL 40838
9 XBRL DEFINITION FILE cocp-20180630_def.xml EX-101.DEF 139813
10 XBRL LABEL FILE cocp-20180630_lab.xml EX-101.LAB 261254
11 XBRL PRESENTATION FILE cocp-20180630_pre.xml EX-101.PRE 201475
Mailing Address 1860 MONTREAL ROAD TUCKER GA 30084
Business Address 1860 MONTREAL ROAD TUCKER GA 30084 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 181003516
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences